RxDoctor Payments Data

Alison Weiner

Psychiatry · Montclair, NJNPI 1346310349

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $41,100 of the $44,458 with a category attached, or 92.4%. AbbVie accounts for 96.2% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $14,118, 2.0 times the $7,044 reported in 2019. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,458in general payments, 2019–2025

Across 146 payments — averaging $304.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$43K
  • Alkermes, Inc.$863
  • Otsuka America Pharmaceutical, Inc.$318
  • Johnson & Johnson$126
  • Vanda Pharmaceuticals Inc.$120
  • Lundbeck LLC$60
  • plus $197 from 7 others

What the payments were for

  • Speaking & faculty fees$41,10092%
  • Food & beverage$3,3117%
  • Education$470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,458 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole11$14,755
Aripiprazole53$12,675
TrintellixVortioxetine Hydrobromide16$11,821
Quetiapine Fumarate116$2,809
Bupropion XlBupropion Hcl71$2,583
Desvenlafaxine Succinate ErDesvenlafaxine Succinate35$1,786
Divalproex Sodium ErDivalproex Sodium35$1,393
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine44$1,015
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$878
Lamotrigine68$833
Venlafaxine Hcl ErVenlafaxine Hcl54$679
Escitalopram Oxalate74$583
Gabapentin54$572
Risperidone70$518
Alprazolam56$450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$318$14,75511 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$27$11,82116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Montclair

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →